Stockreport

UroGen Advances Long-Term Growth Strategy by Acquiring a Next-Generation Investigational Oncolytic Virus (ICVB-1042) and Announces Multiple Strategic Research Collaborations [Yahoo! Financ...

UroGen Pharma Ltd. - Ordinary Shares  (URGN) 
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.urogen.com
PDF - Strategic Research Collaborations Focused on Exploring the Potential of UroGen's Innovative RTGel ® Technology to Enhance the Clinical Effectiveness of Multiple Immun [Read more]